Skip to Content

Join the 'Postherpetic Neuralgia' group to help and get support from people like you.

Postherpetic Neuralgia News

Sorrento Therapeutics Subsidiary, Scilex, Receives FDA Approval for Non-Opioid ZTlido (lidocaine topical system) 1.8% for Post-Herpetic Neuralgia Pain

Posted 11 Mar 2018 by Drugs.com

SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) – Sorrento Therapeutics, Inc. (NASDAQ:SRNE) (“Sorrento”), and its majority-owned subsidiary, Scilex Pharmaceuticals Inc. (“Scilex”), received approval from the U.S. Food and Drug Administration (FDA) for ZTlido (lidocaine topical system) 1.8%. ZTlido is indicated for the relief of pain associated with post-herpetic neuralgia (PHN), also referred to as pos ...

FDA Approves Lyrica CR (pregabalin) Extended-Release Tablets for Neuropathic Pain Conditions

Posted 17 Oct 2017 by Drugs.com

October 12, 2017 - Pfizer Inc. (NYSE: PFE) announced today that the United States Food and Drug Administration (FDA) has approved Lyrica CR (pregabalin) extended-release tablets CV as once-daily therapy for the management of neuropathic pain associated with diabetic peripheral neuropathy (pDPN) and the management of postherpetic neuralgia (PHN). Lyrica CR did not receive approval for the ...

Shingles Vaccine Appears to Cut Odds of Long-Term Pain

Posted 4 Jun 2015 by Drugs.com

TBD, 2015 – Even when shingles vaccination does not prevent the disease, it reduces the risk of long-term pain that can occur as a complication of the condition, according to a new study. Although the U.S. Advisory Council on Immunization Practices recommends shingles vaccination for people 60 and older, vaccination rates remain low, the researchers say. "Hopefully, this study will encourage ...

GSK and XenoPort Receive FDA Approval for Horizant for Postherpetic Neuralgia

Posted 7 Jun 2012 by Drugs.com

LONDON & RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif.--(BUSINESS WIRE)--Jun 7, 2012 - GlaxoSmithKline plc and XenoPort, Inc. announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic neuralgia (PHN) in adults. The efficacy and safety of Horizant for the management of ...

Drug Combo May Offer Best Relief for Nerve Pain

Posted 16 Jul 2010 by Drugs.com

TUESDAY, Sept. 29 – People with nerve pain respond better to a combination treatment using the anticonvulsant gabapentin and antidepressant nortriptyline than to treatment with either drug alone, according to Canadian researchers. The study findings suggest that combination treatment could be used to help people who only partially respond to one drug or the other. Nerve, or neuropathic, pain – ...

NeurogesX Receives FDA Approval of Qutenza (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)

Posted 2 Dec 2009 by Drugs.com

SAN MATEO, Calif., Nov. 16 /PRNewswire-FirstCall/ – NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles. Qutenza delivers a synthetic form ...

Ask a Question

Further Information

Related Condition Support Groups

Neuralgia

Related Drug Support Groups

gabapentin, Lyrica, Neurontin, nortriptyline, clonidine, pregabalin, Lidoderm, Gralise, capsaicin, view more... Horizant, gabapentin enacarbil, Capzasin, Pain Doctor, Capzasin-HP, Zostrix, ZTlido, Capzasin-P, Trixaicin, Sloan's Liniment, Icy Hot PM, Capzasin Back and Body, Pain-X, Gabarone, Drs Cream, Qutenza, Trixaicin HP, Zostrix-HP, Lyrica CR, CidalEaze, R-Gel, No Pain-HP, GNP Capsaicin, Zostrix Neuropathy, Capsin, Dolorac, Axsain, RT Capsin, Salonpas Gel-Patch, Zostrix Sports, Capsicum Oleoresin, Castiva Warming